Bringing some payment activities in-house while outsourcing others can help sponsors optimize clinical trial efficiency, reduce risks, and strengthen site relationships.
Jim DiCesare
Advertisement
Articles by Jim DiCesare
Advertisement
Latest Updated Articles
Why Sponsors Should Consider a Hybrid Approach for Clinical Trial PaymentsPublished: August 13th 2025 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Bringing Clinical Trials Into the Digital Era with eConsent
2
Global Breast Cancer Trials Show Progress in Diversity, But Gaps Remain
3
ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition
4
ACT Brief: Digital Consent, Global Diversity, and Clinical Setbacks Shape Today’s Clinical Research Landscape
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
